Identifying gastric cancer risk before cancer suspicion: <i>Helicobacter pylori</i> prevalence and virulence heterogeneity in a multicenter endoscopy cohort.
Abstract
e22534 Background: Gastric cancer remains a leading cause of cancer mortality worldwide. Helicobacter pylori is a WHO class I carcinogen, yet its detection and characterization in real-world, non-oncologic endoscopy populations remain limited. Identifying modifiable gastric cancer risk before cancer suspicion represents a critical prevention opportunity. Methods: This was a multicenter, cross-sectional study of patients undergoing upper endoscopy for non-oncologic indications at a tertiary center in Mexico. Clinical, endoscopic, histopathologic and lifestyle variables were collected. Gastric biopsies were evaluated by H&E and molecular assays for H. pylori , five virulence-associated genes were identified. Prevalence was estimated with exact 95% Confidence Intervals (CI). Exploratory group comparisons used contingency tables with chi 2 of Fisher exact tests, as appropriate, bilateral p-values were interpreted descriptively. Results: Among 92 biopsies tested molecularly, H. pylori was detected in 28.3% (n = 26, CI 19.4–38.6). In the paired analytic cohort with clinical and questionnaire data (n = 89), H. pylori was identified histologically in 11 samples and differed significantly across gastritis severity categories (p = 0.007), with higher inflammatory activity among positive samples. Premalignant lesions were present in 10% of patients. Molecular profiling revealed substantial virulence heterogeneity, vacA was detected in 85% (n = 22) of H. pylori- positive biopsies, with a wide quantitative range (max. > 17,000 copies), cagA was not detected, while other virulence associated genes showed variable presence. Exploratory analyses suggested associations between H. pylori infection and select socioeconomic and lifestyle factors, including consuming non-purified water. Despite evidence of carcinogenic infection, referred prior eradication therapy was rare. Conclusions: In real-world endoscopy cohort without cancer suspicion, H. pylori infection and inflammation-associated risk states are common and frequently untreated. Results of the characterization and count of virulence-associated genes, suggests risk is not necessarily binary (infected vs not), rather graded, biologically plausible, and measurable at the point of routine care. Treating risk as graded supports pragmatic prevention strategies and endoscopy-based pathways to identify and treat high-risk states.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (11)
Edith Araceli Fernandez-Figueroa
Core B of Innovation in Precision Medicine, National Institute of Genomic Medicine, Tlalpan, DF, Mexico
Esli Nájera Samaniego
School of Medicine and Health Sciences, Tecnologico de Monterrey, Tlalpan, DF, Mexico
Lourdes Guadalupe Pedroza-Teran
Instituto Nacional de Enfermedades Respiratorias “Ismael Cosio Villegas”, Tlalpan, DF, Mexico
Manuel Alejandro López Flores A la Torre
Instituto Nacional de Enfermedades Respiratorias “Ismael Cosio Villegas", Tlalpan, DF, Mexico
Alvaro Valladares-Pasquel
Instituto Nacional de Enfermedades Respiratorias “Ismael Cosio Villegas”, Tlalpan, DF, Mexico
Teresa Vazquez-Alvarez
Core B of Innovation in Precision Medicine, National Institute of Genomic Medicine, Tlalpan, DF, Mexico
Laura Angélica Montes-Aguilar
Translational Medicine Laboratory, National Cancer Institute, Tlalpan, DF, Mexico
Gabriela Cano-Herrera
Core B of Innovation in Precision Medicine, National Institute of Genomic Medicine, Tlalpan, DF, Mexico
Marco Antonio Aguirre-González
Translational Medicine Laboratory, National Cancer Institute, Tlalpan, DF, Mexico
Nayelli Ortiz
Departamento de Gastroenterología, UMAE, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS, Cuauhtémoc, DF, Mexico
Erika Ruiz-García